Abstract
Chronic obstructive pulmonary disease (COPD) is related to infiltration and activation of inflammatory cells in airways and pulmonary tissue. In COPD, neutrophils are prominent, while eosinophilic influx is typical to asthma. Inflammatory cells express sialic acid-binding immunoglobulin like lectins called Siglecs, a family of innate immune receptors that are transmembrane I-type lectins binding sialic acid. One member of the Siglec family, Siglec-8, is expressed mostly in eosinophils and may be an important therapeutic target in asthma or COPD. The aim of our project was to quantify Siglec-8 expression in induced sputum cells of COPD patients treated with long-acting beta2-agonists (LABA) or combined with long-acting antimuscarinic agents (LAMA) – tiotropium bromide. Thirty stable COPD patients (21 males and 9 females, mean age 67 years) receiving 12 μg BID formoterol therapy were assessed before and after 3 months’ add-on therapy consisting of 18 μg QID tiotropium. In all patients, spirometry, lung volumes, and DLCO were performed before and after therapy. The patients were subjected to sputum induction before and after therapy. Sputum cells were isolated and processed to obtain cell membranes. Siglec-8 protein expression was assessed using Western blot. In patients receiving tiotropium and formoterol, improved FEV1 and lung volumes were observed compared with formoterol-only treated patients. The mean Siglec-8 level was significantly higher in eosinophilic subgroup of COPD patients compared with non-eosinophilic patients before therapy 40,000 vs. 15,000 Adj. Vol. INT/mm2. Our data show that Siglec-8 may be involved in COPD pathogenesis and may influence COPD phenotyping.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Pancholi, M., Venge, P., Lomas, D. A., Barer, M. R., Johnston, S. L., Pavord, I. D., & Brightling, C. E. (2012). Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: A randomized placebo-controlled trial. American Journal of Respiratory and Critical Care Medicine, 186, 48–55.
Cao, H., & Crocker, P. R. (2011). Evolution of CD33-related siglecs: Regulating host immune functions and escaping pathogen exploitation? Immunology, 132, 18–26.
GOLD – Global Initiative for Chronic Obstructive Pulmonary Disease (2011). Global strategy for the diagnosis, management and prevention of COPD. Available at: http://www.goldcopd.org. Accessed on 12 Dec 2012.
Holownia, A., Mroz, R. M., Kielek, A., Chyczewska, E., & Braszko, J. J. (2009). Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroids. European Journal of Medical Research, 14(Suppl 4), 104–107.
Holownia, A., Mroz, R. M., Skopinski, T., Kielek, A., Kolodziejczyk, A., Chyczewska, E., & Braszko, J. J. (2010). Tiotropium increases cytosolic muscarinic M3 receptors and acetylated H3 histone proteins in induced sputum cells of COPD patients. European Journal of Medical Research, 15(Suppl 2), 64–67.
Holownia, A., Mroz, R. M., Skopinski, T., Kolodziejczyk, A., Chyczewska, E., & Braszko, J. J. (2013). Tiotropium increases PPARgamma and decreases CREB in cells isolated from induced sputum of COPD patients. Advances in Experimental Medicine and Biology, 756, 9–14.
Kikly, K. K., Bochner, B. S., Freeman, S. D., Tan, K. B., Gallagher, K. T., D’alessio, K. J., Holmes, S. D., Abrahamson, J. A., Erickson-Miller, C. L., Murdock, P. R., Tachimoto, H., Schleimer, R. P., & White, J. R. (2000). Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. The Journal of Allergy and Clinical Immunology, 105, 1093–1100.
Kitaguchi, Y., Komatsu, Y., Fujimoto, K., Hanaoka, M., & Kubo, K. (2012). Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. International Journal of Chronic Obstructive Pulmonary Disease, 7, 283–289.
Mroz, R., Noparlik, J., Chyczewska, E., Braszko, J., & Holownia, A. (2007). Molecular basis of chronic inflammation in lung diseases: New therapeutic approach. Journal of Physiology and Pharmacology, 58(Suppl 5), 453–460.
Rosenberg, H. F., Dyer, K. D., & Foster, P. S. (2013). Eosinophils: Changing perspectives in health and disease. Nature Reviews. Immunology, 13, 9–22. doi:10.1038/nri3341.
Soler-Cataluna, J. J., Cosio, B., Izquierdo, J. L., Lopez-Campos, J. L., Marin, J. M., Aguero, R., Baloira, A., Carrizo, S., Esteban, C., Galdiz, J. B., Gonzalez, M. C., Miravitlles, M., Monso, E., Montemayor, T., Morera, J., Ortega, F., Peces-Barba, G., Puente, L., Rodriguez, J. M., Sala, E., Sauleda, J., Soriano, J. B., & Viejo, J. L. (2012). Consensus document on the overlap phenotype COPD-asthma in COPD. Archivos de Bronconeumologia, 48, 331–337.
Varki, A. (1992). Selectins and other mammalian sialic acid-binding lectins. Current Opinion in Cell Biology, 4, 257–266.
Varki, A., & Crocker, P. R. (2009). I-type lectins. In A. Varki, R. D. Cummings, J. D. Esko, H. H. Freeze, P. Stanley, C. R. Bertozzi, G. W. Hart, & M. E. Etzler (Eds.), Essentials of glycobiology. New York: Cold Spring Harbor.
Varki, A., & Gagneux, P. (2012). Multifarious roles of sialic acids in immunity. Annals of the New York Academy of Sciences, 1253, 16–36.
Varki, N. M., & Varki, A. (2007). Diversity in cell surface sialic acid presentations: Implications for biology and disease. Laboratory Investigation, 87, 851–857.
Conflicts of Interest
The authors had no conflicts of interest to declare in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Mroz, R.M. et al. (2013). Siglec-8 in Induced Sputum of COPD Patients. In: Pokorski, M. (eds) Neurobiology of Respiration. Advances in Experimental Medicine and Biology, vol 788. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6627-3_3
Download citation
DOI: https://doi.org/10.1007/978-94-007-6627-3_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6626-6
Online ISBN: 978-94-007-6627-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)